Below are 4 news articles from the past 7 days to help guide you in making your decision. Articles that are from known reputable sources have been flagged with "Trusted: True".

Article 1 of 4
Title: Hamilton hospital emergency wait times at ‘crisis levels’ — more than 2 hours
Publisher: insauga.com
Trusted: False
Posted: 2 days ago
The article is relevant for forecasting COVID-19 hospitalizations in Ontario, Canada. Here is a brief summary highlighting values most important for forecasting COVID-19 hospitalizations in Ontario, Canada: The article reports on the current state of emergency wait times in Hamilton hospitals, which are at "crisis levels" with an average wait time of 2.05 hours, higher than the provincial average of 1.9 hours. The data shows a correlation between provincial COVID-19 lockdown measures and wait times, with shorter wait times during periods of lockdown (e.g., 1.27 hours in April 2021) and longer wait times when lockdown measures are lifted. The article mentions that the expiry of mask mandates in medical settings is expected to worsen the situation. The article also highlights the impact of vaccination on hospitalizations, noting that vaccination won't provide enough relief due to factors such as children under five not being vaccinated, healthcare workers being parents, and the risk of Long Covid. Values most important for forecasting COVID-19 hospitalizations in Ontario, Canada: Average wait times in Hamilton hospitals (2.05 hours) Provincial average wait time (1.9 hours) Correlation between lockdown measures and wait times Impact of vaccination on hospitalizations Expiry of mask mandates in medical settings These values can inform forecasting models by highlighting the current strain on hospitals, the impact of lockdown measures, and the potential effects of vaccination and mask mandates on hospitalizations.

Article 2 of 4
Title: Toronto's medical officer of health contracts COVID-19
Publisher: CP24
Trusted: False
Posted: 3 days ago
The article is relevant for forecasting COVID-19 hospitalizations in Ontario, Canada. Here is a brief summary of the key points: The Medical Officer of Health for Toronto, Dr. Eileen de Villa, has tested positive for COVID-19, but is experiencing mild symptoms due to being up-to-date on her vaccinations. The article mentions that according to provincial data, COVID-19 hospitalizations in Ontario are declining. However, wastewater data, which measures levels of the virus, is showing a slight increase. The values most important for forecasting COVID-19 hospitalizations in Ontario, Canada are: The decline in hospitalizations, which suggests a potentially decreasing trend in severe cases. The increase in wastewater data, which could indicate a potential uptick in cases or community spread. These values could be used to inform forecasting models, taking into account the potential impact of vaccination rates and community spread on hospitalization numbers.

Article 3 of 4
Title: FDA Declines Authorization of Fluvoxamine SSRI for COVID Treatment
Publisher: Verywell Mind
Trusted: False
Posted: 4 days ago
This article is relevant for forecasting COVID-19 hospitalizations in Ontario, Canada, as it discusses the potential use of fluvoxamine as a treatment for COVID-19 and its possible impact on hospitalizations. The article highlights the following key points relevant to forecasting COVID-19 hospitalizations in Ontario: 1. The FDA declined to authorize fluvoxamine as a treatment for COVID-19, citing insufficient evidence of its effectiveness in preventing severe disease and/or hospitalization. 2. A study in Brazil found that patients who received fluvoxamine early on were 32% less likely to need hospitalization or emergency care for more than six hours. 3. Ontario's COVID-19 Advisory has approved the use of fluvoxamine if other treatments are unavailable, but recommends using other treatments like sotrovimab (Xevudy) and remdesivir (Veklury) when available. 4. Fluvoxamine is relatively affordable and could potentially be used as a cheap oral treatment for COVID-19, which could impact hospitalizations and deaths. These points suggest that fluvoxamine may have some potential in reducing hospitalizations, but more research is needed to confirm its effectiveness. This information can be considered when forecasting COVID-19 hospitalizations in Ontario, particularly in scenarios where fluvoxamine is used as a treatment.

Article 4 of 4
Title: EU agency sees risk of COVID deaths rising as Omicron subvariants spread
Publisher: CTV News
Trusted: False
Posted: 5 days ago
The article is relevant for forecasting COVID-19 hospitalizations in Ontario, Canada. Here is a brief summary of the key points: Two new subvariants of Omicron, BA.4 and BA.5, are spreading rapidly in Europe and may lead to increased hospitalizations and deaths as they become dominant. In countries where BA.5 has become prevalent (e.g., Portugal), there have been surges in overall cases. BA.4 and BA.5 do not appear to carry a higher risk of severe disease than other forms of Omicron, but increased transmission rates could lead to more hospitalizations and deaths. The European Centre for Disease Prevention and Control (ECDC) expects BA.4 and BA.5 to become dominant due to their growth advantage. Values most important for forecasting COVID-19 hospitalizations in Ontario, Canada: The proportion of BA.4 and BA.5 cases in Ontario (currently unknown) The growth rate of BA.4 and BA.5 cases in Ontario (currently unknown) The current hospitalization rate in Ontario (not mentioned in the article) To better forecast COVID-19 hospitalizations in Ontario, it would be essential to monitor the spread of BA.4 and BA.5 in the province and assess their impact on hospitalization rates.